3.0
21. Aug. 2019
Ehemaliger Mitarbeiter, mehr als 5 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Myriad is a large company, benefits are good, comp is competitive
Kontras
The main product Genesight has lost 2 of its panels (from 4), the product is inferior, the money to be made will decrease significantly, competitors will move in and take over